ROSCOVITINE(Seliciclib)
产品编号: DC4124
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
Seliciclib (Roscovitine) 是一种口服有效的，选择性的 CDKs 抑制剂，抑制 CDK5，Cdc2 和 CDK2 的 IC50 分别为0.2 μM，0.65 μM，0.7 μM。
| Cas No.: |
186692-46-6 |
| 名称: |
(R)-2-(6-(benzylamino)-9-isopropyl-9H-purin-2-ylamino)butan-1-ol |
| 别名: |
Seliciclib |
| SMILES: |
CC[C@H](CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C |
| 分子式: |
C19H26N6O |
| 分子量: |
354.45 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
Description of Seliciclib: Seliciclib is an orally bioavailable, small-molecule cyclin-dependent kinase (CDK) inhibitor with potential proapoptotic and antineoplastic activities. Seliciclib primarily inhibits CDK2/E, CDK2/A, CDK7 and CDK9 by competing Fo |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
COA
| LOT NO. |
DOWNLOAD |
|
|
| 2018-0101 |
|
询盘
